Related Experiment Video
Updated: Aug 2, 2025

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Altered coronary artery function, arteriogenesis and endothelial YAP signaling in postnatal hypertrophic
Paulina Langa1,2, Richard J Marszalek1,2, Chad M Warren1,2
1Department of Physiology and Biophysics, College of Medicine, University of Illinois at Chicago, Chicago, IL, United States.
Insights
Early hypertrophic cardiomyopathy (HCM) involves sarcomere dysfunction, leading to diastolic dysfunction and coronary flow issues. These defects precede structural changes, highlighting early mechano-transduction signaling alterations in HCM pathogenesis.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Cardiac Physiology
Background:
- Hypertrophic cardiomyopathy (HCM) is a genetic heart disease primarily caused by mutations in sarcomere proteins.
- Understanding the early mechanisms of HCM progression, particularly how sarcomeric biophysical signals are transduced, remains incomplete.
- This study investigates early HCM development focusing on myofilament dysfunction during neonatal growth.
Purpose of the Study:
- To examine cardiac dynamics, coronary vascular structure and function, and mechano-transduction signaling in mice with a thin-filament HCM mutation during neonatal development.
- To identify early cellular and molecular events that precede overt hypertrophic remodeling in HCM.
- To elucidate the role of sarcomeric biophysical signal transduction in HCM pathogenesis.
Main Methods:
- Studied transgenic (TG) TG-cTnT-R92Q and non-transgenic (NTG) mice from postnatal days 7-28 (P7-P28).
- Employed techniques including skinned fiber mechanics, echocardiography, biochemistry, histology, and immunohistochemistry.
- Analyzed myofilament Ca2+-sensitivity, cardiac function, coronary vascular parameters, fibrosis, and mechano-transduction signaling (YAP expression).
Main Results:
- Increased myofilament Ca2+-sensitivity was observed at P7 in TG mice, persisting through P28.
- Significant diastolic dysfunction and coronary flow perturbation were present at P7, accompanied by localized fibrosis.
- By P14, arteriolar structure declined, fibrosis expanded, and endothelial YAP expression showed altered nuclear-to-cytosolic ratios, indicating disrupted mechano-transduction signaling.
Conclusions:
- Early mechanisms in HCM pathogenesis involve defective sarcomeric biophysical signals leading to diastolic dysfunction.
- Impacts on coronary flow dynamics, arteriogenesis, and fibrosis are driven by these early sarcomeric defects.
- Altered mechano-transduction signaling between cellular compartments contributes significantly to HCM development.
Abstract:
Introduction: Hypertrophic cardiomyopathy (HCM) is a cardiovascular genetic disease caused largely by sarcomere protein mutations. Gaps in our understanding exist as to how maladaptive sarcomeric biophysical signals are transduced to intra- and extracellular compartments leading to HCM progression. To investigate early HCM progression, we focused on the onset of myofilament dysfunction during neonatal development and examined cardiac dynamics, coronary vascular structure and function, and mechano-transduction signaling in mice harboring a thin-filament HCM mutation. Methods: We studied postnatal days 7-28 (P7-P28) in transgenic (TG) TG-cTnT-R92Q and non-transgenic (NTG) mice using skinned fiber mechanics, echocardiography, biochemistry, histology, and immunohistochemistry. Results: At P7, skinned myofiber bundles exhibited an increased Ca2+-sensitivity (pCa50 TG: 5.97 ± 0.04, NTG: 5.84 ± 0.01) resulting from cTnT-R92Q expression on a background of slow skeletal (fetal) troponin I and α/β myosin heavy chain isoform expression. Despite the transition to adult isoform expressions between P7-P14, the increased Ca2+- sensitivity persisted through P28 with no apparent differences in gross morphology among TG and NTG hearts. At P7 significant diastolic dysfunction was accompanied by coronary flow perturbation (mean diastolic velocity, TG: 222.5 ± 18.81 mm/s, NTG: 338.7 ± 28.07 mm/s) along with localized fibrosis (TG: 4.36% ± 0.44%, NTG: 2.53% ± 0.47%). Increased phosphorylation of phospholamban (PLN) was also evident indicating abnormalities in Ca2+ homeostasis. By P14 there was a decline in arteriolar cross-sectional area along with an expansion of fibrosis (TG: 9.72% ± 0.73%, NTG: 2.72% ± 0.2%). In comparing mechano-transduction signaling in the coronary arteries, we uncovered an increase in endothelial YAP expression with a decrease in its nuclear to cytosolic ratio at P14 in TG hearts, which was reversed by P28. Conclusion: We conclude that those early mechanisms that presage hypertrophic remodeling in HCM include defective biophysical signals within the sarcomere that drive diastolic dysfunction, impacting coronary flow dynamics, defective arteriogenesis and fibrosis. Changes in mechano-transduction signaling between the different cellular compartments contribute to the pathogenesis of HCM.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Regulation of Angiogenesis and Blood Supply
Coronary Artery Disease II: Pathophysiology
Myocarditis I: Introduction

